Work

Neutrophil-to-lymphocyte ratio as a prognostic factor and its relationship to patient (pt) outcomes in the RAINBOW trial.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.438

Authors: Kei Muro, Jaffer A. Ajani, Zev A. Wainberg, Holly Knoderer, Ran Wei, Anindya Chatterjee, Paolo Abada, Atsushi Ohtsu

Institutions: Aichi Cancer Center, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, Eli Lilly (United States), National Cancer Center Hospital East

Language: English

Topic: Inflammatory Biomarkers in Disease Prognosis

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W3004549998

Cites:

Cited by: 1

Related to: 10